{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T17:07:35Z","timestamp":1754154455230,"version":"3.41.2"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404921"],"award-info":[{"award-number":["82404921"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brazilian Journal of Otorhinolaryngology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bjorl.2025.101636","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T12:18:13Z","timestamp":1745583493000},"page":"101636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Causal relationship and potential pathogenic mechanisms between rosacea with pharyngeal and laryngeal cancer"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5938-1690","authenticated-orcid":false,"given":"Zexin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9074-7629","authenticated-orcid":false,"given":"Xiaoxue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjorl.2025.101636_bib0005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s40257-021-00595-7","article-title":"Rosacea: new concepts in classification and treatment","volume":"22","author":"van Zuuren","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0010","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1056\/NEJMcp1506630","article-title":"Rosacea","volume":"377","author":"van Zuuren","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjorl.2025.101636_bib0015","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jaad.2013.04.043","article-title":"Rosacea: current state of epidemiology","volume":"69","author":"Tan","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0020","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/jdv.13556","article-title":"Prevalence of rosacea in the general population of Germany and Russia \u2013 the RISE study","volume":"30","author":"Tan","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0025","first-page":"282","article-title":"Incidence and prevalence of rosacea: a systematic review and meta-analysis","volume":"179","author":"Gether","year":"2018","journal-title":"Br J Dermatol"},{"issue":"6, Supplement 1","key":"10.1016\/j.bjorl.2025.101636_bib0030","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jaad.2013.04.045","article-title":"New insights into rosacea pathophysiology: a review of recent findings","volume":"69","author":"Steinhoff","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.bjorl.2025.101636_bib0035","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/jid.2015.53","article-title":"Assessment of the genetic basis of rosacea by genome-wide association study","volume":"135","author":"Chang","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0040","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaad.2019.05.063","article-title":"A randomized phase 3b\/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea","volume":"82","author":"Schaller","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0045","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/bjd.15155","article-title":"DOMINO, doxycycline 40 mg vs. minocycline 100 mg in the treatment of rosacea: a randomized, single-blinded, noninferiority trial, comparing efficacy and safety","volume":"176","author":"van der Linden","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0050","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/bjd.19172","article-title":"An exploratory, open\u2010label, investigator\u2010initiated study of interleukin\u201017 blockade in patients with moderate\u2010to\u2010severe papulopustular rosacea","volume":"183","author":"Kumar","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0055","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000444082","article-title":"Patients with rosacea have increased risk of depression and anxiety disorders: a Danish nationwide cohort study","volume":"232","author":"Egeberg","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.bjorl.2025.101636_bib0060","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s40257-016-0217-1","article-title":"Nationwide assessment of cause-specific mortality in patients with rosacea: a cohort study in Denmark","volume":"17","author":"Egeberg","year":"2016","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0065","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s13555-023-00964-6","article-title":"The relationship between rosacea and inflammatory bowel disease: a systematic review and meta-analysis","volume":"13","author":"Jun","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.bjorl.2025.101636_bib0070","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jamaneurol.2016.0022","article-title":"Exploring the association between rosacea and Parkinson disease","volume":"73","author":"Egeberg","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0075","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1111\/jocd.14389","article-title":"Relationship between rosacea and chronic obstructive pulmonary disease","volume":"21","author":"Demirba\u015f","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0080","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/bjc.2015.217","article-title":"Personal history of rosacea and risk of incident cancer among women in the US","volume":"113","author":"Li","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bjorl.2025.101636_bib0085","article-title":"Detecting potential causal relationship between inflammatory bowel disease and rosacea using bi-directional Mendelian randomization","volume":"13","author":"Li","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.bjorl.2025.101636_bib0090","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/sim.7221","article-title":"A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization","volume":"36","author":"Bowden","year":"2017","journal-title":"Stat Med"},{"key":"10.1016\/j.bjorl.2025.101636_bib0095","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/ije\/dyv071","article-title":"Mendelian randomization studies: a review of the approaches used and the quality of reporting","volume":"44","author":"Boef","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0100","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0105","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ijc.32871","article-title":"Global trends in oral and pharyngeal cancer incidence and mortality","volume":"147","author":"Bosetti","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bjorl.2025.101636_bib0110","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jamaoncol.2023.2960","article-title":"The global, regional, and national burden of adult lip, oral, and pharyngeal cancer in 204 countries and territories: a systematic analysis for the global burden of disease study 2019","volume":"9","author":"Cunha","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0115","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jamaoto.2016.3421","article-title":"Association between laryngeal cancer and asbestos exposure","volume":"143","author":"Ferster","year":"2017","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.bjorl.2025.101636_bib0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nic.2021.08.009","article-title":"Postoperative pharynx and larynx","volume":"32","author":"Hostetter","year":"2022","journal-title":"Neuroimaging Clin N Am"},{"key":"10.1016\/j.bjorl.2025.101636_bib0125","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hed.23866","article-title":"Risk factors for dysphagia after transoral videolaryngoscopic surgery for laryngeal and pharyngeal cancer","volume":"38","author":"Tomifuji","year":"2015","journal-title":"Head Neck"},{"key":"10.1016\/j.bjorl.2025.101636_bib0130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canep.2017.01.006","article-title":"Rosacea and risk of cancer in Denmark","volume":"47","author":"Egeberg","year":"2017","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0135","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/1346-8138.14918","article-title":"Potential association between rosacea and cancer: a study in a medical center in southern China","volume":"46","author":"Long","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0140","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v102.2563","article-title":"Risk of skin cancer and actinic keratosis in patients with rosacea: a nationwide population-based cohort study","volume":"102","author":"Cho","year":"2022","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0145","doi-asserted-by":"crossref","DOI":"10.2196\/47821","article-title":"Rosacea and its association with malignancy: systematic review","volume":"6","author":"Thapa","year":"2023","journal-title":"JMIR Dermatol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0150","doi-asserted-by":"crossref","DOI":"10.1111\/srt.13737","article-title":"Novel insights into rosacea\u2019s role in cancer risk: a Mendelian randomization approach","volume":"30","author":"Luo","year":"2024","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0155","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaad.2014.08.028","article-title":"Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors","volume":"72","author":"Two","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0160","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.det.2017.11.001","article-title":"Rosacea pathogenesis","volume":"36","author":"Ahn","year":"2018","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.bjorl.2025.101636_bib0165","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/exd.13314","article-title":"Friends or foes? Host defense (antimicrobial) peptides and proteins in human skin diseases","volume":"26","author":"Niyonsaba","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0170","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/jid.2015.141","article-title":"Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of Th1\/Th17 pathways","volume":"135","author":"Buhl","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/jid.2011.259","article-title":"Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands","volume":"132","author":"Morizane","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00005-015-0359-5","article-title":"The role of cathelicidin LL-37 in cancer development","volume":"64","author":"Piktel","year":"2015","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.bjorl.2025.101636_bib0185","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.7150\/thno.30726","article-title":"Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt\/\u03b2-catenin signaling","volume":"9","author":"Ji","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bjorl.2025.101636_bib0190","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1365-2133.2010.09957.x","article-title":"The antimicrobial peptide human cationic antimicrobial protein-18\/cathelicidin LL-37 as a putative growth factor for malignant melanoma","volume":"163","author":"Kim","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0195","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/bjd.14703","article-title":"The many faces of interleukin-17 in inflammatory skin diseases","volume":"175","author":"Speeckaert","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0200","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/s41590-019-0514-y","article-title":"IL-17 receptor-based signaling and implications for disease","volume":"20","author":"Li","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0205","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3928504","article-title":"Salivary IL-17A, IL-17F, and TNF-\u03b1 are associated with disease advancement in patients with oral and oropharyngeal cancer","volume":"2020","author":"Zieli\u0144ska","year":"2020","journal-title":"J Immunol Res"},{"key":"10.1016\/j.bjorl.2025.101636_bib0210","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/jdv.19732","article-title":"Biomarkers in rosacea: a systematic review","volume":"38","author":"Geng","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.bjorl.2025.101636_bib0215","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41573-024-01053-9","article-title":"Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer","volume":"23","author":"Croft","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bjorl.2025.101636_bib0220","doi-asserted-by":"crossref","first-page":"j5375","DOI":"10.1136\/bmj.j5375","article-title":"Modifiable pathways in Alzheimer\u2019s disease: Mendelian randomisation analysis","volume":"359","author":"Larsson","year":"2017","journal-title":"BMJ"}],"container-title":["Brazilian Journal of Otorhinolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1808869425000795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1808869425000795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T10:18:40Z","timestamp":1753352320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1808869425000795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1808869425000795"],"URL":"https:\/\/doi.org\/10.1016\/j.bjorl.2025.101636","relation":{},"ISSN":["1808-8694"],"issn-type":[{"type":"print","value":"1808-8694"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Causal relationship and potential pathogenic mechanisms between rosacea with pharyngeal and laryngeal cancer","name":"articletitle","label":"Article Title"},{"value":"Brazilian Journal of Otorhinolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjorl.2025.101636","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Associa\u00e7\u00e3o Brasileira de Otorrinolaringologia e Cirurgia C\u00e9rvico-Facial. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101636"}}